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With improved treatments and increasingly life expectancy, the burden of metastatic disease in the spine is expected to rise. The
role of conventional surgery for spinal metastases is well established but often involves procedures of large magnitude. We describe
minimally invasive techniques for spinal stabilization and decompression in patients with symptomatic metastatic disease of the
spine.
1.Introduction
Metastatic disease to the spine is an increasingly common
clinical condition given improved cancer care and overall
mortality trends. The majority of patients who die of cancer
have vertebral metastases at autopsy [1, 2]. An estimated
20,000 patients per year in the United States have symp-
tomaticepiduralspinalcordcompressionandamuchgreater
number have symptomatic vertebral metastases [3, 4]. The
clinical burden in other areas of the world is likely similar.
Surgical management is entertained in patients who have
spinal instability and/or compressive neurologic deﬁcits [5].
Although there are rare indications for formal en bloc
resection of metastatic tumors, the vast majority of patients
with metastatic disease in the spine are treated with palliative
intent. These patients are often weakened as a consequence
of their primary disease process as well as its attendant treat-
ments (e.g., chemotherapy and radiotherapy).
Open surgical treatment has a well-established clinical
record in the treatment of patients with metastatic disease to
the spine [6, 7]. However, advancements in surgical tech-
nique, instrumentation, and imaging modalities have led to
the development of minimally invasive surgical techniques
(MIS) in the treatment of metastatic disease to the spine.
These procedures seek to decrease the physiologic insult,
recovery time, and morbidity of more traditional open spine
procedures. As well, they often allow more rapid initiation of
other treatments (chemotherapy, radiotherapy) postopera-
tively than would be permitted by traditional approaches
alone. MIS surgery of the spine seeks to achieve equivalent or
superior outcomes to those of traditional open spine surgery
with the use of these techniques. It is important to recognize,
however, that the safety and eﬃcacy of these techniques are
currentlyunderinvestigationanddependonsurgeonexperi-
ence and patient selection. This paper will review techniques
commonly employed in minimally invasive spine surgery for
metastatic disease. Percutaneous augmentation techniques
(vertebroplasty/kyphoplasty) may be used in concert with
these procedures but are not the focus of this paper.
2. Indications/Contraindications
Patients are considered for MIS treatment of spinal metas-
tases if they require stabilization with or without tumor
decompression. Relative contraindications to these tech-
niques include circumferential tumors (in which adequate
decompression may be diﬃcult to achieve through an MIS
approach alone). As well, highly vascular tumors (e.g., renal
cell carcinoma) which require decompression with a high
risk of resulting epidural hematoma may best be approached
through open procedures in which proper hemostasis can
be assured. Finally, it must be recognized that currently
available MIS instrumentation is not as strong as the
strongest traditional open instrumentation. Thus, patients
who lack anterior column support should probably not
undergostand-aloneMISposteriorinstrumentationwithout
concordant techniques to increase anterior column support2 International Journal of Surgical Oncology
(e.g., concurrent vertebro/kyphoplasty, surgical instillation
of methylmethacrylate, or cage insertion). The recent devel-
opment of cobalt chrome rods for use in MIS systems
improves the biomechanical proﬁle of these instrumentation
sets but does not remove these concerns.
3.SurgicalTechniques
Common surgical techniques used in minimally invasive
surgery for spinal metastases include posterior pedicle
screw-based stabilization applied percutaneously, limited
opendecompressiveprocedures,percutaneousextracavitary/
costotransversectomy type approaches accessed through a
paraspinal muscle splitting mechanism, and direct lateral
approaches. These techniques may be used in combination
and may be further coupled with vertebro/kyphoplasty
procedures to maximize the repertoire of disease which may
be addressed in this manner.
Excepting rare and unique circumstances, we do not
recommend decompression without instrumentation in the
treatment of metastatic disease. The presence of the tumor
itself is generally a destabilizing inﬂuence on the spine,
and the bony removal necessary for decompression leads to
further destabilization. Even if the assessment at the time of
surgery is that appropriate remaining bone stock is present,
with progression of disease, there is a high likelihood of
spinal instability developing. Thus, posterior instrumenta-
tion is a standard part of MIS spine tumor treatment in our
hands.
Spinal stabilization without formal fusion is usually the
goal of these procedures. We do not pursue an extensive
decortication or bone grafting in the treatment of metastatic
disease. Bony fusion is unlikely to ever be achieved in the
hostile environment containing a tumor which is treated
by adjuvant chemo- and/or radiotherapy. The decortication
used to promote bony fusion disrupts natural anatomic
barriers to further tumor inﬁltration and spread, increases
the scope of the procedure beyond its oncologic goals, and
removes/weakens further stabilizing bone stock. If cavities
remain which require ﬁlling for structural support, we prefer
to achieve this with the use of methylmethacrylate and/or
further instrumentation. Note that the United States Food
and Drug Administration considers spinal instrumentation
without fusion in this manner to be an “oﬀ-label” use of
these devices. The authors employ this technique for the
clinical reasons outlined above and inform their patients of
thisdiscrepancybetweenhowthesedevicesareapprovedand
how they are used in these unique clinical situations.
3.1. Technique: MIS Posterior Pedicle Screw Instrumentation.
Percutaneouspediclescrewinstrumentationisusedinnearly
all MIS metastatic tumor surgeries by our group (Figure 1).
Patients are positioned prone upon a radiolucent operating
table.Imagingisusuallyachievedthroughtheuseofbiplanar
ﬂuoroscopy. Alternatively, an intraoperative CT scanner and
stereotacticnavigation with appropriate referencelandmarks
may be used at the surgeon’s discretion. We prefer to drape
in two ﬂuoroscopy units to allow eﬃcient AP and lateral
imaging to be obtained.
At the discretion of the operating surgeon, instrumen-
tation may be placed through a series of paraspinal stab
incisions, two parallel longitudinal paraspinal incisions, or
a single mid-line incision. If a single mid-line incision is
used, dissection is generally taken down to the level of the
dorsal interfascial plane, and instrumentation is then placed
through small individual fascial incisions.
Usingbiplanarﬂuoroscopy,pediclesarecannulatedusing
a cannulated awl. Guidewires are then placed through each
cannula. Cannulated taps are used to establish the pedicle
screw trajectory, and pedicle screws are then placed over
these guidewires. The guidewire is removed once the screw
is inserted. Screwdrivers or reduction towers may remain in
place as a mechanism to allow manipulation of the vertebral
body (to correct deformity) and provide for locking screws
to be placed once the stabilizing posterior rods are in place.
Once ﬁxation points are all placed, rods are passed
percutaneously through the screw heads and locked in place.
A separate paraspinal stab incision is generally used to allow
entry of the rods proximal to distal. In the lower lumbar
spine, the lordotic orientation of L4-S1 sometimes makes
it easier to pass rods from caudal to cranial. Once the rods
are locked in place, the instruments used to place the screws
are removed, the wound is irrigated and then closed in the
standard fashion.
As patients with metastatic disease often have involve-
ment at levels adjacent to the primary pathology, it is our
preference to err on the side of a greater number of ﬁx-
ation points to distribute any stresses over a greater area,
decreasing the risk of catastrophic failure. In practice, we
generally instrument with bipedicular ﬁxation two to three
levels above and two to three levels below the site of disease
in this manner. Instrumentation (or spannage) of six to ten
levels is commonly achieved. Percutaneous instrumentation
isalsousedtoprovidesupplementalﬁxationforpatientswho
have undergone limited open anterior procedures (Figure 2).
3.2. Combined Miniopen Decompression. In conjunction
with the percutaneous instrumentation described above,
miniopen decompression may be used to remove dorsal or
dorsal-lateral areas of tumor compression. As well, in cases
below the conus medullaris, anterolateral decompression
may be achieved through this route as well with gentle ma-
nipulation of the thecal sac.
Patients undergoing a miniopen posterior decompres-
sion have a short segment mid-line incision performed over
the area of oﬀending pathology. Dissection is then taken
down to allow for limited laminectomy and tumor removal
(Figure 3). Any dorsal tumor is easily removed via this
approach. As well, the medial portion of the pedicle on
either side may be removed and angled instruments can be
usedtoachieveadecompressionofdorsal-lateral,lateral,and
anterolateral tumor compression.
This approach is very helpful when the surgeon suspects
the tumor may be hypervascular. This miniopen approach
allows proper exposure for hemostasis and a high degreeInternational Journal of Surgical Oncology 3
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Figure 1: Percutaneous pedicle screw instrumentation. (a) Dual ﬂuoroscopy setup; (b) percutaneous cannulation of pedicles; (c, d) lateral
and anteroposterior imaging of pedicle cannulation; (e) passage of pedicle screws; (f) percutaneous passage of rod.
of conﬁdence that a postoperative hematoma is unlikely.
Limited open approaches also provide the best access if
unilateral rhizotomy are necessary to access oﬀending tumor
or to repair any dural tears which occur. No special imaging
capabilities beyond basic ﬂuoroscopy for level localization
and percutaneous pedicle screw placement is necessary for
this technique.
3.3. Percutaneous Extracavitary/Costotransversectomy Tech-
nique. More extensive ventral and lateral tumor may be
resected through the use of a percutaneous extracavi-
tary/costotransversectomyapproach. This utilizes the Wiltsie
interval to access the lateral half of the dural tube as well
as the ventral epidural space. This procedure requires more
specialized instrumentation. Surgery relies upon the use of
dilating percutaneous retractors which are docked over the
surgical region of interest and held ﬁxed by arms which
attach to the operating table frame (Figure 4). These are
usually used in conjunction with an operating microscope
and bayoneted instruments to allow appropriate access.
Percutaneous extracavitary decompressions are coupled
with posterior pedicle screw instrumentation placed percu-
taneously. The incision for the dilating retractor to allow
the decompression is done 5 to 7cm oﬀ the mid-line as
dictated by local anatomy and the trajectory of the approach.
Radiographic localization may be by ﬂuoroscopy or via
intraoperative navigation, depending on surgeon preference
andfacilitycapabilities.Thistechniqueallowsmoreextensive4 International Journal of Surgical Oncology
Figure 2: Use of percutaneous posterior instrumentation to stabi-
lize open L5 corpectomy.
(a)
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Figure 3: Miniopen decompression combined with percutaneous
instrumentation. (a) Limited open decompression; (b) view of
decompressed dural tube during rod passage.
Figure 4: Setup for bilateral extracavitary approach showing dilat-
ing retractors inserted oﬀ midline rigidly attached to the operative
table.
decompression of ventral tumor masses than does a min-
iopen posterior approach alone. Access to the posterior
vertebral body may be obtained for curettage of tumor or
augmentation with cement. We have found that methyl-
methacrylatemaybeeasilyinstilledintotumorcavitiesinthe
vertebral body accessed in this manner using a conventional
PMMA cement gun with a small diameter nozzle typically
used for implantation of shoulder and elbow arthroplasty
components. When cementis injected in this manner, a cage,
Steinmann pin, or small fragment screw is placed into the
adjacent bone, and the cement is placed around it. This acts
as an additional anchor to prevent migration of cement.
3.4. Direct Lateral Approach for Tumor Removal. Percuta-
neous systems now oﬀer direct lateral access to the L1
through L4 vertebral bodies. Similar instruments may be
used in conjunction with a minithoracotomy to access
disease in the thoracic vertebral bodies. In much the same
manner of an MIS extracavitary approach, a direct lateral
approach may be used to access vertebral body disease. It
is not our preference to resect epidural tumor extension
through this approach as the visualization of the thecal sac is
inferior to that achieved through an extracavitary approach.
This approach does allow for resection of the anterior
vertebral body and reconstruction with a cage or methyl-
methacrylate. Because of the overhanging iliac wing, the L5
vertebral body is not well accessed in this manner.
4. IllustrativeCaseExample
Percutaneous ﬁxation, bilateral extracavitary approach, and
vertebral body reconstruction with cage and methyl-
methacrylate were employed in the successful treatment ofInternational Journal of Surgical Oncology 5
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Figure 5: Bilateral extracavitary decompression for metastatic ﬁbrosarcoma. (a) Sagittal T2-weighted, and (b) axial gadolinium enhanced
MR images demonstrate pathologic fracture and metastatic epidural spinal cord compression at T5. (c) Fluoroscopy demonstrating
docking of extracavitary retractors over the T5 costovertebral region. (d) Postoperate radiograph demonstrating T2–T8 ﬁxation with cage
+ methylmethacrylate reconstruction of T5. (e) Postoperative CT demonstrates bilateral extracavitary decompression with cage/cement
reconstruction.6 International Journal of Surgical Oncology
a 37-year-old woman presenting with thoracic myelopa-
thy from metastatic ﬁbrosarcoma. Initial imaging studies
demonstrate pathologic fracture of T5 with high-grade
metastatic epidural spinal cord compression (Figures 5(a)
and 5(b)). Patient underwent surgical treatment with percu-
taneous pedicle screw ﬁxation spanning T2–T8 with bilateral
extracavitary decompression at T5. Note that ﬂuoroscopic
imaging demonstrates docking of dilating retractors over
the T5 costovertebral junction (Figure 5(c)). After tumor
removal, a cage and methylmethacrylate were inserted to
help reconstruct the weakened T5 body (Figure 5(d)). Post-
operative CT demonstrates the resection achieved as well as
cage/methylmethacrylate reconstruction. The patient recov-
ered neurologic function post-operatively.
5. Discussion
Preliminary results of minimally invasive treatment of spinal
metastases are encouraging [8]. Instrumentation failure is
rare, and with proper adjuvant treatment, patients are
unlikely to succumb to local mechanical or disease-related
failure prior to demise. Most procedures can be performed
with limited blood loss and modest operative times.
A beneﬁt to the use of MIS approaches to metastatic
spine tumors in our practice is a more rapid initiation
of postoperative adjuvant therapies. For example, after a
conventional open instrumented costotransversectomy pro-
cedure, we are hesitant to allow initiation of chemo- or
radiotherapy until four to six weeks following the procedure
to guard against wound dehiscence given the large approach,
empty/dead space, and tissue devitalization which occurs
with such procedures. In contrast, after an MIS extra-
cavitary decompression and percutaneous instrumentation
procedure, stereotactic radiotherapy may be initiated at
our institution 10 to 14 days postoperatively. Although the
percutaneousproceduremaynotallowacompletedebulking
of oﬀending tumor from the vertebral body, the excellent
local control (even of adverse histologies) achieved by
stereotactic radiotherapy decreases the need for a gross total
resection of tumor and may change the treatment paradigm
of some patients with metastatic disease [9]. Our goal in
the MIS treatment of these patients is to achieve a zone of
decompression around the thecal sac of 2 to 4mm followed
by the rapid initiation of stereotactic radiotherapy to achieve
local disease stasis.
We emphasize that the adoption of these techniques
by our surgical oncology group has been in a progressive
fashion. There is certainly a learning curve associated with
the implementation of MIS techniques in any setting. Given
the altered anatomy and tissue conditions caused by tumor,
radiotherapy, and so forth in the oncologic situation, this
learning curve/case progression is highlighted. Our group
began using MIS techniques for stabilization procedures
aloneandthenexpandedthemtotheuseofstabilizationcou-
pled with miniopen decompressions and now pursue MIS
extracavitary decompression of metastatic epidural spinal
cord compression.
To date, our experience has been encouraged with low
morbidity and favorable clinical and oncologic outcomes
(Clarke et al., manuscript under review). Further experience
will be necessary to reﬁne the indications and techniques
for MIS surgery applied to metastatic disease. Open surgical
stabilization and decompression remain the gold standard to
which MIS results must be compared. Direct comparative
studies of open versus MIS treatments for metastatic disease
in the spine are not currently available. Acknowledging
these limitations, MIS techniques oﬀer a valuable option
for consideration in patients presenting with symptomatic
metastatic disease of the spine.
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